FK 506 versus cyclosporine A for steroid-free synergistic combination therapy with rapamycin in a discordant large animal donor xenoislet transplant model.
Troppmann
C
C
Department of Surgery, University of Minnesota, Minneapolis 55455, USA.
Papalois
B E
BE
Gruessner
A C
AC
Nakhleh
R E
RE
Gruessner
R W
RW
D000704:Analysis of Variance; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000628:therapy*; D004285:Dogs; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology* / Q000502:physiology; D011090:Polyenes / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D020123:Sirolimus; D016559:Tacrolimus / Q000627:therapeutic use*; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000502:physiology
D001786:Blood Glucose; D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D020123:Sirolimus; D016559:Tacrolimus